Edesa Biotech, Inc.EDSANASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank80
3Y CAGR-7.7%
5Y CAGR-26.8%
Year-over-Year Change
Research and development spending
3Y CAGR
-7.7%/yr
vs +44.6%/yr prior
5Y CAGR
-26.8%/yr
Recent acceleration
Acceleration
-52.3pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $3.77M | +2.9% |
| 2025 | $3.67M | +27.3% |
| 2024 | $2.88M | -39.9% |
| 2023 | $4.79M | -64.0% |
| 2022 | $13.34M | -25.7% |
| 2021 | $17.95M | +439.0% |
| 2020 | $3.33M | +203.7% |
| 2019 | $1.10M | -47.5% |
| 2018 | $2.09M | +5.8% |
| 2017 | $1.97M | - |